0000947871-12-000329.txt : 20120319
0000947871-12-000329.hdr.sgml : 20120319
20120319181605
ACCESSION NUMBER: 0000947871-12-000329
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120315
FILED AS OF DATE: 20120319
DATE AS OF CHANGE: 20120319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DE LA TOUR DAUVERGNE LAURAGUAIS BERNARD P
CENTRAL INDEX KEY: 0001284255
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16625
FILM NUMBER: 12701734
BUSINESS ADDRESS:
STREET 1: BUNGE LTD
STREET 2: 50 MAIN ST
CITY: WHITE PLAINS
STATE: NY
ZIP: 10606
BUSINESS PHONE: 9146842800
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bunge LTD
CENTRAL INDEX KEY: 0001144519
STANDARD INDUSTRIAL CLASSIFICATION: FATS & OILS [2070]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 MAIN STREET
STREET 2: 6TH FLOOR
CITY: WHITE PLAINS
STATE: NY
ZIP: 10606
BUSINESS PHONE: 914-684-2800
MAIL ADDRESS:
STREET 1: 50 MAIN STREET
STREET 2: 6TH FLOOR
CITY: WHITE PLAINS
STATE: NY
ZIP: 10606
FORMER COMPANY:
FORMER CONFORMED NAME: BUNGE LTD
DATE OF NAME CHANGE: 20010710
4
1
ss140441_4-delatour.xml
OWNERSHIP DOCUMENT
X0304
4
2012-03-15
0
0001144519
Bunge LTD
BG
0001284255
DE LA TOUR DAUVERGNE LAURAGUAIS BERNARD P
C/O BUNGE LTD., 50 MAIN STREET
6TH FLOOR
WHITE PLAINS,
NY
10606
1
0
0
0
Common Stock
2012-03-15
4
S
0
2535
67.63
D
325298
D
Common Stock
2012-03-15
4
M
0
7200
21.61
A
332498
D
Common Stock
3
I
Spouse
Stock Option (right to buy)
21.61
2012-03-15
4
M
0
7200
0
D
2003-01-01
2012-05-24
Common Stock
7200
0
D
All of the transactions reported on this Form 4 were effected pursuant to a written 10b5- l trading plan adopted in accordance with SEC Rule 10b5-1.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.60 to $67.80, inclusive. The reporting person undertakes to provide to Bunge Ltd., any security holder of Bunge Ltd., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
/s/ John Tropeano, Attorney-in-Fact
2012-03-19